Side-by-side comparison of AI visibility scores, market position, and capabilities
Commercial/defense aircraft maker in deep crisis; $66.5B FY2024 revenue; 2024 Alaska Airlines door blowout + IAM strike + $14B equity raise; new CEO Kelly Ortberg Aug 2024; Airbus gaining market share.
Boeing is one of the world's two dominant commercial aircraft manufacturers and a major defense and space contractor, founded in 1916 by William Boeing in Seattle, Washington and now headquartered in Arlington, Virginia—relocated from Chicago in 2022. The company trades on NYSE (BA) and reported approximately $66.5 billion in revenues for FY2024 under CEO Kelly Ortberg, who replaced Dave Calhoun in August 2024 amid a deepening quality and manufacturing crisis. Boeing's commercial aircraft division—the 737 MAX, 787 Dreamliner, and 777X—has been plagued by a series of safety, quality, and production crises beginning with the two fatal 737 MAX crashes in 2018 and 2019 (Lion Air and Ethiopian Airlines, killing 346 people), followed by a door plug blowout on an Alaska Airlines 737-9 MAX in January 2024 that triggered renewed FAA production rate restrictions and public confidence damage.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.